DavisSL, VazquezJA, McKinnonPS. Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients. Ann Pharmacother2007; 41: 568-73. Epub 20 Mar 2007. DOI 10.1345/aph.1H516
2.
ShorrAF, LazarusDR, ShernerJH. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia. Crit Care Med2007; 35: 1077-83.
3.
BlotS, JanssensR, ClaeysG. Effect of fluconazole consumption on long-term trends in candidal ecology. J Antimicrob Chemother2006; 58: 474-7.
4.
BlotS, VandewoudeK, HosteE, PoelaertJ, ColardynF.Outcome in critically ill patients with candidal fungaemia: Candida albicans vs Candida glabrata.J Hosp Infect2001; 47:308-13.
